Lisa von Moltke - 07 Feb 2025 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Signature
/s/ Thomas J. DesRosier, attorney-in-fact for Lisa von Moltke
Issuer symbol
MCRB
Transactions as of
07 Feb 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 16:15:04 UTC
Previous filing
19 Nov 2024
Next filing
19 Feb 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (Right to Buy) Award $0 +650,000 $0.000000 650,000 07 Feb 2025 Common Stock 650,000 $0.7820 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on February 7, 2026. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

Executive Vice President and Chief Medical Officer